Evidence map›Paper›PMID 30596102›Full record

ArticleBioMed research international2018

The Chinese Medicinal Formulation Guzhi Zengsheng Zhitongwan Modulates Chondrocyte Structure, Dynamics, and Metabolism by Controlling Multiple Functional Proteins.

Baojin Yao, Bocheng Lu, Mei Zhang, Hongwei Gao, Xiangyang Leng, Daqing Zhao

Abstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Baojin YaoJilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin 130117, China.
Bocheng LuThe Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin 130117, China.
Mei ZhangInnovation Practice Center, Changchun University of Chinese Medicine, Changchun, Jilin 130117, China.
Hongwei GaoThe Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin 130117, China.
Xiangyang LengThe Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin 130117, China.ORCID 0000-0001-5278-4001
Daqing ZhaoJilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin 130117, China.ORCID 0000-0001-5678-7410

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional Chinese medicine is one of the oldest medical systems in the world and has its unique principles and theories in the prevention and treatment of human diseases, which are achieved through the interactions of different types of materia medica in the form of Chinese medicinal formulations. GZZSZTW, a classical and effective Chinese medicinal formulation, was designed and created by professor Bailing Liu who is the only national medical master professor in the clinical research field of traditional Chinese medicine and skeletal diseases. GZZSZTW has been widely used in clinical settings for several decades for the treatment of joint diseases. However, the underlying molecular mechanisms are still largely unknown. In the present study, we performed quantitative proteomic analysis to investigate the effects of GZZSZTW on mouse primary chondrocytes using state-of-the-art iTRAQ technology. We demonstrated that the Chinese medicinal formulation GZZSZTW modulates chondrocyte structure, dynamics, and metabolism by controlling multiple functional proteins that are involved in the cellular processes of DNA replication and transcription, protein synthesis and degradation, cytoskeleton dynamics, and signal transduction. Thus, this study has expanded the current knowledge of the molecular mechanism of GZZSZTW treatment on chondrocytes. It has also shed new light on possible strategies to further prevent and treat cartilage-related diseases using traditional Chinese medicinal formulations.

Indexed as

AnimalsBiological ProductsChondrocytesDNA ReplicationDrugs, Chinese HerbalMateria MedicaMedicine, Chinese TraditionalMiceMice, Inbred C57BLProteinsProteomicsSignal TransductionTranscription, GeneticBiological ProductsDrugs, Chinese HerbalMateria MedicaProteins

Identifiers

PMID30596102
PMCPMC6282133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.